$390,000 of EQUIFAX INC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to S. 2144 - A bill to improve the safety and security of Members of Congress, immediate family members of Members of Congress, and congressional staff; Issues related to incarceration information; Issues related to Government Benefit Eligibility Verification; Issues related to the One Big Beautiful Bill Act (P.L. 119-21). Issues related to the use of credit reports for mortgage; Issues related to credit reporting. General issues related to the National Defense Authorization Act for Fiscal Year 2026; Issues related to Department of Defense Appropriations for Fiscal Year 2026. Issues related to the Supplemental Nutrition Assistance Program; Issues related to the One Big Beautiful Bill Act (P.L. 119-21); Issues related to eligibility verification. Issues related to student loans, public service loan forgiveness, and income-driven repayment plans. Issues related to H.R. 1177/S. 492 - Improve and Enhance the Work Opportunity Tax Credit Act; Issues related to labor and unemployment insurance verifications. Issues related to the Combat Methamphetamine Epidemic Act of 2005 (P.L. 109-177). Issues related to the Earned Income Tax Credit; Issues related to tax administration."
You can find more data on corporate lobbying on Quiver Quantitative.
EFX Insider Trading Activity
EFX insiders have traded $EFX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $EFX stock by insiders over the last 6 months:
- MARK W BEGOR (CEO) has made 0 purchases and 6 sales selling 70,424 shares for an estimated $17,352,490.
- JOHN W JR GAMBLE (EVP, CFO & COO) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $1,260,250.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EFX Hedge Fund Activity
We have seen 418 institutional investors add shares of EFX stock to their portfolio, and 339 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,143,594 shares (-16.2%) from their portfolio in Q2 2025, for an estimated $296,613,975
- JPMORGAN CHASE & CO removed 849,502 shares (-58.4%) from their portfolio in Q2 2025, for an estimated $220,335,333
- VAN ECK ASSOCIATES CORP removed 777,633 shares (-49.9%) from their portfolio in Q2 2025, for an estimated $201,694,671
- HARRIS ASSOCIATES L P added 537,230 shares (+11.8%) to their portfolio in Q2 2025, for an estimated $139,341,345
- CAPITAL INTERNATIONAL INVESTORS added 403,723 shares (+4.0%) to their portfolio in Q2 2025, for an estimated $104,713,634
- MERITAGE GROUP LP removed 402,901 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $104,500,432
- CEREDEX VALUE ADVISORS LLC removed 343,618 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $89,124,200
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EFX Analyst Ratings
Wall Street analysts have issued reports on $EFX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 10/15/2025
- Needham issued a "Buy" rating on 10/08/2025
- RBC Capital issued a "Outperform" rating on 09/25/2025
- UBS issued a "Buy" rating on 09/15/2025
- Baird issued a "Outperform" rating on 07/23/2025
- Citigroup issued a "Buy" rating on 07/23/2025
- Oppenheimer issued a "Outperform" rating on 07/23/2025
To track analyst ratings and price targets for EFX, check out Quiver Quantitative's $EFX forecast page.
EFX Price Targets
Multiple analysts have issued price targets for $EFX recently. We have seen 17 analysts offer price targets for $EFX in the last 6 months, with a median target of $285.0.
Here are some recent targets:
- Jason Haas from Wells Fargo set a target price of $285.0 on 10/15/2025
- Rayna Kumar from Oppenheimer set a target price of $271.0 on 10/13/2025
- Kyle Peterson from Needham set a target price of $295.0 on 10/08/2025
- Heather Balsky from B of A Securities set a target price of $250.0 on 10/03/2025
- Keith Mackey from RBC Capital set a target price of $15.0 on 09/25/2025
- Kevin Mcveigh from UBS set a target price of $297.0 on 09/15/2025
- Andrew Steinerman from JP Morgan set a target price of $272.0 on 07/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
